Further reinforcing the clinical relevance of cfRNAs, studies have shown that HPGD’s involvement in the prostaglandin metabolic pathway is crucial for understanding its impact on tumor growth and the inflammatory microenvironment surrounding cancers [12]. The gene discussed is HPGD; the disease is cancer.